Zwitterionic Polymer Matrices for hESC Culture Stability

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Human embryonic stem cells (hESCs) are challenging to maintain in an undifferentiated state due to their sensitivity to environmental influences, and current culture methods rely on xenogenic matrices that are prone to contamination and batch-to-batch inconstancies, limiting their widespread use in research and clinical applications.

Innovation Solution

Development of synthetic polymer matrices, specifically zwitterionic polymers like poly[2-(methacryloyloxy)ethyl dimethyl-(3-sulfopropyl)ammonium hydroxide] (PMEDSAH) and its copolymers, which provide a well-defined and reproducible environment for hESC culture, allowing for long-term undifferentiated growth and pluripotency maintenance.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If xenogenic culture matrices (mouse or human embryonic fibroblast cells, MATRIGEL, laminin, or fibronectin) are used to support hESC growth, then cell adhesion and proliferation are improved, but batch-to-batch inconstancies and contamination risks increase

Engineering Contradiction:
ImprovehESC culture stabilityVSAvoidmatrix reproducibility
Core Design Contradiction:
ReliabilityVSEase of manufacture

Solution Approach 1:

The patent modifies the chemical parameters of synthetic polymer matrices by incorporating specific peptide sequences (RGD, YIGSR, LDV) and controlling their density, arrangement, and conformational states to replicate the biological functionality of xenogenic matrices while achieving reproducibility and eliminating contamination risks

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent creates composite synthetic matrices combining multiple peptide sequences with controlled spatial arrangements and conformational states on polymer surfaces to achieve both cell adhesion functionality and batch-to-batch consistency, replacing natural extracellular matrix components with engineered synthetic composites

Inventive Principle:
Principle #40Composite materials

2Reliability

If co-culture systems with fibroblasts are used to maintain hESCs, then cell survival and undifferentiated state are improved, but direct studies of self-renewal and differentiation mechanisms become complicated

Engineering Contradiction:
ImprovehESC undifferentiated maintenanceVSAvoidculture system complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent extracts and isolates the specific adhesive peptide sequences from complex fibroblast extracellular matrices and presents them on synthetic surfaces, eliminating the need for live fibroblast co-culture while maintaining the essential cell-adhesion functions required for hESC undifferentiated maintenance

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent uses synthetic polymer surfaces functionalized with specific peptide sequences as intermediaries to provide the necessary cell-adhesion signals, replacing the complex fibroblast-mediated support system with a simplified synthetic mediator that maintains hESC pluripotency without the complexity of living cell co-culture

Inventive Principle:
Principle #24Intermediary (Mediator)

3Ease of manufacture

If synthetic polymer matrices are used as cell culture substrates, then fabrication reproducibility and contamination resistance are improved, but long-term hESC culture capability has not yet been established

Engineering Contradiction:
Improvematrix fabrication consistencyVSAvoidhESC culture duration
Core Design Contradiction:
Ease of manufactureVSDuration of action of stationary object

Solution Approach 1:

The patent systematically varies parameters including peptide sequence composition, surface density, spatial arrangement, and conformational mobility to optimize synthetic matrix properties for long-term hESC culture, achieving both fabrication reproducibility and extended culture capability

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent develops composite synthetic matrices incorporating multiple peptide sequences with controlled conformational states and spatial arrangements that provide sustained cell-adhesion signals necessary for long-term culture while maintaining batch-to-batch consistency through precise synthetic control

Inventive Principle:
Principle #40Composite materials

Data Source

PatentUS9487750B2Methods and compositions for growth of cells and embryonic tissue on a synthetic polymer matrix
Publication Date: 2016.11.08 THE RGT UNIV OF MICHIGAN
  • US9487750B2 patent drawing
  • US9487750B2 patent drawing
  • US9487750B2 patent drawing

AI summary

The present invention provides methods and compositions for establishing and maintaining growth of cells and embryonic tissue on a synthetic polymer matrix. For example, the present invention provides synthetic growth matrices for stem cells, gametes, mature differentiated cells, and embryonic tissue (e.g., blastomeres, embryos, and embryoid bodies). In certain embodiments, the cells are capable of going through multiple passages while remaining in an undifferentiated state as a result of the synthetic polymer matrix.